D. Ross Ramidge, University of Colorado Denver (IMAGE)
Caption
D. Ross Camidge, M.D., Ph.D., investigator at the University of Colorado Cancer Center and colleagues report promising results of rociletinib against EGFR-positive lung cancer.
Credit
CU Cancer Center
Usage Restrictions
None
License
Licensed content